FOXO4-DRI Testing & Verification
FOXO4-DRI is a niche, higher-cost research peptide sold across an unregulated market where vial labels are rarely backed by independent data. KMD Analytical verifies what is actually in your sample by RP-HPLC-UV against a certified reference standard where one can be sourced.
What FOXO4-DRI is
FOXO4-DRI is a synthetic senolytic research peptide built as a D-retro-inverso (DRI) construct: the amino-acid sequence is reversed and assembled entirely from D-amino acids, a design that resists enzymatic degradation while preserving the intended side-chain topology. It is a relatively long peptide (roughly 48 residues, including an N-terminal cell-penetrating import motif) with a molecular weight in the several-thousand-g/mol range. Because every residue is D-configured, its chromatographic and spectral behavior is distinctive but also easy to get wrong — an incorrectly built (partly L-configured or truncated) sequence is a different molecule. It is sold strictly on the research market with no regulated identity or content guarantee, which is exactly why independent verification is worthwhile.
Why get your FOXO4-DRI independently tested
- Identity for a hard-to-make sequence: an all-D, reversed-sequence peptide of this length is demanding to synthesize correctly. Retention-time and UV-spectral matching against a certified reference standard confirms the vial matches genuine FOXO4-DRI rather than a mis-synthesized or substituted peptide.
- Net-peptide content vs. label: as an expensive, low-volume peptide, FOXO4-DRI vials are a target for underfilling. A net-peptide assay reports the actual milligrams of peptide per vial rather than the number on the label.
- Long-sequence impurities: assembling a ~48-residue chain leaves ample opportunity for deletion, truncation, and incomplete-coupling by-products. Chromatographic purity as area percent quantifies how much of the detectable material is the target peak versus related substances.
- Filler vs. product: lyophilized vials are routinely bulked with mannitol or other excipients, so a full-looking cake can be mostly bulking agent. The assay separates true peptide mass from filler.
What we measure on FOXO4-DRI
We analyze your sample by reversed-phase HPLC with UV/diode-array detection at 214 nm and report three results per certificate: identity (retention-time and UV-spectral match against a certified FOXO4-DRI reference standard), chromatographic purity as area percent of the main peak, and net-peptide assay as milligrams of peptide per vial. Identity depends on a suitable certified reference standard being available for comparison.
Every result is issued as a certificate of analysis you — or anyone you forward it to — can verify cryptographically. Reporting identity, purity, and milligram content is the point: a vial can be pure and still underfilled, so we report all three. More on purity vs. net-peptide content and how to read a peptide COA.
Our scope — stated plainly
FOXO4-DRI is an uncommon peptide, so a certified reference standard often must be sourced and qualified before analysis — which can add meaningful lead time, and in some cases limit what we can offer. RP-HPLC-UV establishes identity by retention-time and UV-spectral match; it does not confirm D- versus L-configuration, the retro-inverso arrangement, or exact molecular mass, which would require orthogonal methods such as mass spectrometry that we do not perform. KMD Analytical is an independent laboratory.
KMD is an independent RP-HPLC-UV lab. We do not run LC-MS / mass-spec, sterility, endotoxin, or heavy-metal testing. If your job needs a capability we don't have, we'll say so.
FOXO4-DRI testing — FAQ
Can you confirm my FOXO4-DRI is genuinely all-D / retro-inverso?
Not directly. RP-HPLC-UV establishes identity by matching retention time and UV spectrum to a certified reference standard, which distinguishes genuine FOXO4-DRI from a materially different or mis-built sequence. It does not measure stereochemistry (D vs. L) or the retro-inverso arrangement itself — that requires orthogonal techniques such as mass spectrometry and chiral analysis, which are outside our scope.
Will there be extra lead time to test FOXO4-DRI?
Likely yes. FOXO4-DRI is a low-volume, less-common peptide, so a certified reference standard may need to be sourced and qualified before we can run a valid identity and assay comparison. We confirm standard availability and any lead time with you before proceeding, since every result is measured against that standard.
What exactly is on the certificate?
Three results: identity (match to a certified reference standard), chromatographic purity as area percent, and net-peptide assay in milligrams per vial. These are analytical characterization results, not a safety, sterility, or fitness-for-use determination.
Other peptides we test
Retatrutide · Cagrilintide · Tesamorelin · BPC-157 · see the full panel.